MHRA’s proposed Early Access route aims to put breakthrough medical devices in patients’ hands sooner
The Medicines and Healthcare products Regulatory Agency (MHRA) has released a Statement of Policy Intent that details its proposals for how an Early Access Service…
New regulatory pathway set to support safe patient access to innovative medtech
The Medicines and Healthcare products Regulatory Agency (MHRA) is set to launch the Innovative Devices Access Pathway (IDAP) later in 2023. IDAP is designed to…


